US medical device developer buys Israeli start-up for $920 million


In one of Israel’s most successful exits for a biomedical start-up, HeartWare Int’l, a U.S.-based medical device developer, acquires Valtech Cardio, a developer of heart valve repair & replacement technology.

By Hezi Sternlicht, Israel Hayom Staff & News Agencies


Israeli medical startup Valtech Cardio announced Wednesday that it had been acquired by global medical device developer HeartWare International. The deal is estimated at $920 million, making it one of the most successful exits for an Israeli biomedical company.

Valtech Cardio develops innovative surgical instruments – Screenshot: Valtech


View original Israel Hayom publication at: